Investors

Corporate Profile

Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and pain management, and has an interest in expanding into additional specialty segments. The Company promotes its branded products to physicians through its two Pernix sales forces and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc.

Investor Events

Q3 2016 Pernix Therapeutics Holdings Inc Earnings Conference Call
Thursday, November 10, 2016 4:30 p.m. ET
View more
Q2 2016 Pernix Therapeutics Holdings Inc Earnings Conference Call
Thursday, August 11, 2016 4:30 p.m. ET
View more